Tag: Subcutaneous infusion

Remodulin (treprostinil) is a medication for patients with pulmonary arterial hypertension (PAH) delivered via a continuous infusion pump. Accurate calculation is essential to ensure correct administration, and understanding **how to calculate Remodulin** infusion parameters is critical for safe and effective use.

Xembify is a 20% subcutaneous immune globulin (SCIG) replacement therapy approved for treating primary humoral immunodeficiency disease (PI) in patients aged 2 and older. For most patients, this treatment is administered at home following training from a healthcare professional. This guide will detail exactly how is Xembify administered, ensuring a safe and effective self-infusion process.

Remodulin (treprostinil) is a prescription medication used to treat pulmonary arterial hypertension (PAH), which can improve a patient's exercise capacity and reduce associated symptoms. Learning how to use Remodulin correctly is crucial, as it is administered via a continuous subcutaneous or intravenous infusion using a specialized pump.

Immunoglobulin replacement therapy, such as Cuvitru, is the standard treatment for individuals with antibody deficiencies. This article explains how does Cuvitru work by providing the necessary antibodies to protect patients with primary immunodeficiency from recurrent bacterial and viral infections.

In a 2022 Phase III clinical trial, continuous Produodopa treatment led to a significant increase in daily 'on' time for people with advanced Parkinson's disease. **What is Produodopa?** It is an innovative, continuous-infusion therapy designed to manage severe motor fluctuations that are no longer adequately controlled by oral medications.